Shiri Navon‐Venezia

Multidrug-Resistant <i>Pseudomonas aeruginosa</i> : Risk Factors and Clinical Impact

Valerie Aloush, Shiri Navon‐Venezia, Yardena Seigman-Igra et al. · Antimicrobial Agents and Chemotherapy · 2005 · 607 citations · Full text

Pathogenic Microbiology, Antibiotic Resistance, Drug Resistance +16

Molecular Epidemiology of KPC-Producing <i>Klebsiella pneumoniae</i> Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258

Brandon Kitchel, J. Kamile Rasheed, Jean B. Patel et al. · Antimicrobial Agents and Chemotherapy · 2009 · 529 citations · Full text

Predictors of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality

Mitchell J. Schwaber, Shiri Klarfeld-Lidji, Shiri Navon‐Venezia et al. · Antimicrobial Agents and Chemotherapy · 2007 · 482 citations · Full text

Klebsiella Pneumoniae, Logistic Analysis, Drug Resistance +17

Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing <i>Enterobacteriaceae</i>

Mitchell J. Schwaber, Shiri Navon‐Venezia, Keith S. Kaye et al. · Antimicrobial Agents and Chemotherapy · 2006 · 408 citations · Full text

Non-esbl Producers, Esbl-producing Escherichia Coli, Antimicrobial Stewardship +14

Influx of Extended-Spectrum  -Lactamase--Producing Enterobacteriaceae into the Hospital

Ronen Ben‐Ami, Mitchell J. Schwaber, Shiri Navon‐Venezia et al. · Clinical Infectious Diseases · 2006 · 320 citations